Greetings from the MediBloc team!
It is our great honor to announce that Handok has newly joined as a corporate validator of Panacea.
What is a Corporate Validator?
Panacea is a blockchain platform optimized for health data and developed by MediBloc Limited to create a safe and sustainable ecosystem for patients to regain sovereignty over their health data.
In particular, last month, MediBloc Limited launched a Panacea-based Data Exchange Protocol(DEP) on testnet, and is stabilizing it with related companies and institutions. MediBloc will release DEP within the first quarter of this year and invite everyone to participate so that we can expand and upgrade the ecosystem.
Panacea’s corporate validators are responsible for major decision-making and the consensus node operations of Panacea’s technology and business based on blockchain governance, including DEP.
Introducing Handok Pharmaceutical
Handok, which joins as a corporate validator, has contributed to the advancement of the domestic pharmaceutical industry by forming partnerships with the world’s leading pharmaceutical companies since its establishment in 1954. As Korea’s leading total healthcare company, Handok has been continuing its innovative challenge to secure future growth and expand its global expansion. Handok is also focusing on developing innovative biopharmaceuticals, targeted agents in cancer, and medical devices by conducting competitive research and development. In addition, they provide various healthcare products and services such as OTC drugs, ETC drugs, health supplements, and special medical foods.
Expected Benefits
With the joining of Handok, the two companies expect to start discussions such as an active medical data ecosystem based on the Panacea blockchain technology. In addition, we will hold consultations on the establishment of patient convenience services based on Handok’s various services and products provided as a total healthcare company.
Panacea will operate transparently and healthily through the activation of the corporate validator. Following the Mainnet upgrade, which activated validator participation, several leading companies representing the healthcare and IT industries have expressed their intention to participate in this venture. MediBloc Limited is also accelerating the composition and expansion of the ecosystem via internal procedures. In this way, MediBloc Limited will continue to make efforts to secure the high scalability of the Panacea ecosystem through various collaborations.